Litcius/Paper detail

Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?

Niki Katsiki, Ele Ferrannini

2020Journal of Diabetes and its Complications92 citationsDOIOpen Access PDF

Topics & Concepts

MedicineExenatideLiraglutideAlogliptinEmpagliflozinDapagliflozinSaxagliptinSitagliptinMetforminLinagliptinDiabetes mellitusPioglitazoneType 2 diabetesVildagliptinInternal medicineEndocrinologyDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerCOVID-19 Clinical Research Studies
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era? | Litcius